These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23483195)

  • 1. Expression of HAUSP in gliomas correlates with disease progression and survival of patients.
    Cheng C; Niu C; Yang Y; Wang Y; Lu M
    Oncol Rep; 2013 May; 29(5):1730-6. PubMed ID: 23483195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HAUSP promoted the growth of glioma cells in vitro and in vivo via stabilizing NANOG.
    Cheng CD; Dong YF; Niu WX; Niu CS
    Pathol Res Pract; 2020 Apr; 216(4):152883. PubMed ID: 32088087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator.
    Bhattacharya S; Ghosh MK
    FEBS J; 2014 Jul; 281(13):3061-78. PubMed ID: 24823443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.
    Xu Y; Yuan J; Zhang Z; Lin L; Xu S
    Mol Biol Rep; 2012 Sep; 39(9):8979-85. PubMed ID: 22714920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of FAT10 is correlated with progression and prognosis of human glioma.
    Yuan J; Tu Y; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
    Pathol Oncol Res; 2012 Oct; 18(4):833-9. PubMed ID: 22402871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of SMAD4 in gliomas correlates with progression and survival of patients.
    He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
    J Exp Clin Cancer Res; 2011 Jul; 30(1):70. PubMed ID: 21791112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity.
    Lee KW; Cho JG; Kim CM; Kang AY; Kim M; Ahn BY; Chung SS; Lim KH; Baek KH; Sung JH; Park KS; Park SG
    J Biol Chem; 2013 Nov; 288(46):32886-96. PubMed ID: 24072712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of a disintegrin and metalloproteinase-17 in patients with gliomas.
    Wu B; Sha L; Wang Y; Xu W; Yu Y; Feng F; Sun C; Xia L
    Oncol Lett; 2014 Dec; 8(6):2616-2620. PubMed ID: 25364437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
    Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
    Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ADP-ribosyltransferase 1 Is Associated with Poor Prognosis of Glioma Patients.
    Li Z; Yan X; Sun Y; Yang X
    Tohoku J Exp Med; 2016 Aug; 239(4):269-78. PubMed ID: 27466078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
    Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
    Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
    Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of N-methylpurine-DNA glycosylase influences patient survival in malignant gliomas.
    Liu C; Tu Y; Yuan J; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
    J Biomed Biotechnol; 2012; 2012():760679. PubMed ID: 22496614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.
    Men D; Liang Y; Chen L
    Cancer Epidemiol; 2014 Apr; 38(2):152-6. PubMed ID: 24559637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression level of human miR-34a correlates with glioma grade and prognosis.
    Gao H; Zhao H; Xiang W
    J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance.
    Wang H; Wu W; Wang HW; Wang S; Chen Y; Zhang X; Yang J; Zhao S; Ding HF; Lu D
    Neuro Oncol; 2010 Jul; 12(7):679-86. PubMed ID: 20164241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD24 expression as a marker for predicting clinical outcome in human gliomas.
    Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
    J Biomed Biotechnol; 2012; 2012():517172. PubMed ID: 22500096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas.
    Hu Q; Huang K; Tao C; Zhu X
    J Cell Mol Med; 2020 May; 24(10):5888-5900. PubMed ID: 32301283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.